Development and proposal of a proprietary customer support system

「We will carry out this merger to strengthen the functions of the customer-support system in the pharmaceutical wholesaling business. Through this merger, we aim to further improve and accelerate system-development capabilities and maximize corporate value across the Group.」

「For medical appointment scheduling systems, the company newly released LXMATE HeLios cloud and focused on sales promotion activities. It is also advancing the integration of AI functions into existing systems and strengthening promotion.」

「We began handling the cloud-based picking audit system “EveryPick” provided by the company. We are also collaborating with the company and the Japan Pharmaceutical Association, a public interest incorporated association, on the development of the pharmacy DX platform service “N-Bridge” and the prescription-information transmission terminal “NB station.”」

「For the customer support business, the company actively pursued proposals for EveryPick, a cloud-based picking audit system provided by ファルモ, with which it entered into a capital and business alliance in June. It is also cooperating on N-Bridge, a new pharmacy DX platform service being developed by ファルモ and the Japan Pharmaceutical Association, and NB Station, a prescription information transmission terminal. Specifically, the company is providing technology from ENI Pharmacy, its prescription transmission system with a track record of adoption by many medical institutions, and will contribute to the service's ongoing functional improvements and nationwide adoption.」

「In addition, with the aim of building regional healthcare design and advancing its customer support business, the company entered into a business alliance with ファルモ, which operates an ICT business for pharmacies. By integrating ファルモ's Every series, a comprehensive DX solution for dispensing pharmacies' in-person operations, with the company's inventory management system and other customer support systems, the company will strengthen and expand both companies' services and proceed with developing new products that contribute to regional healthcare DX.」

「For customer support systems, the company worked to strengthen promotion using video and remote detailing, promote adoption of the ENIFvoice series, particularly at drugstores, promote the transition from ENIF to Future ENIF, and strengthen proposals for the Hospital Navi website service.」

「For customer support systems, the company worked to promote adoption of ENIFvoice SP, the transition from ENIF to Future ENIF, and stronger proposals for the Hospital Navi website service.」

「For customer support systems, adoption of ENIFvoice SP and the transition from ENIF to Future ENIF progressed, contributing to higher profits.」

「For customer support systems, the number of sites adopting ENIFvoice SP and Future ENIF increased, contributing to higher profits.」

「For customer support systems, the company actively pursued proposals for the enhanced app version of KAITOS, the Initial Consultation Reception Service and the Mizaru pharmacy headquarters system. It also began online promotional activities using the remote detailing service provided by its subsidiary エンタッチ.」

「For customer support systems, the company reviewed the functions of KAITOS, its online consultation and medication guidance system, and released an app version offering greater user convenience. The Initial Consultation Reception Service also continued to expand steadily, with more than 76,000 patients using it per month, contributing to higher group profits.」

「For customer support systems, the company newly released FutureENIF-WEB, the web version of the ENIF pharmaceutical ordering and information terminal, in May. Because orders can now be placed from tablets as well as PCs, the system is expected to be particularly useful in home healthcare. The Initial Consultation Reception Service also continued to expand steadily, with a record monthly total of more than 73,000 users in June, contributing to higher group profits.」

「For customer support systems, the company worked on proposing systems that help reduce opportunities for physical contact and improve patient convenience and customer operating efficiency, including the remote detailing service, KAITOS, the Initial Consultation Reception Service, the Mizaru pharmacy headquarters system and the Future ENIF pharmaceutical ordering and information terminal. Monthly fees collected from customers steadily increased, contributing to higher profits.」

「For customer support systems, monthly fees collected from customers, which account for most of the profit in addition to initial implementation fees, have steadily increased and made a significant contribution to raising group profits. In particular, the Initial Consultation Reception Service handled a record monthly number of more than 70,000 people in September, and the number of users is continuing to grow steadily. The company is also actively providing systems suited to current needs, such as the Mizaru pharmacy headquarters system and medical appointment scheduling systems, which reduce opportunities for physical contact during the COVID-19 pandemic. For its voice recognition system, the company is conducting demonstration tests with medical institutions toward developing a new system.」

「For the remote detailing service developed in cooperation with エンタッチ株式会社, the company newly signed contracts with 4 pharmaceutical companies covering 4 products during the current consolidated fiscal year, bringing the total since the initiative began in the previous consolidated fiscal year to 6 pharmaceutical companies and other businesses covering 7 products.」

「For its proprietary customer support systems that address issues faced by patients and medical institutions, the company began offering KAITOS, an online consultation and medication guidance system, as a new product on 5 February 2021. The entire group will work on this initiative to meet the needs of both patients who wish to receive medical care with peace of mind and medical institutions that wish to provide safe and reliable medical services to patients.」

「The company worked to strengthen relationships with customers by offering a remote detailing service in cooperation with エンタッチ株式会社, its capital alliance partner, and by proposing customer support systems such as the Initial Consultation Reception Service and Future ENIF. It also worked to reduce expenses through changes in work styles and reviews of business processes.」

「The company also worked to promote customer support systems including the Initial Consultation Reception Service and Future ENIF, while reducing expenses through changes in work styles and reviews of business processes.」

「In addition to newly releasing Future ENIF, a pharmaceutical ordering and information terminal with built-in LTE connectivity, in June 2019, the company worked to promote the adoption of the Initial Consultation Reception Service, ENIFvoice SP+A, ENIFvoice Core and Core-POS.」

「The company worked to promote the adoption of proprietary customer support systems including the Initial Consultation Reception Service, the pharmacy headquarters system Mizaru, formerly known as ENIF Headquarters, ENIFvoice SP+A and ENIFvoice Core.」

「At the company, too, sales revenue, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent all significantly exceeded the initial plan, due in part to growth in sales of new drugs such as cancer treatments, specialty pharmaceuticals and orphan drugs, as well as the expansion of customer support systems.」

「The company continued to negotiate unit prices for individual products in line with their respective value, while also working to promote the adoption of proprietary customer support systems such as the Initial Consultation Reception Service, ENIF Headquarters and ENIFvoice Core.」

「In addition, the company reached a basic agreement with 株式会社スズケン in July 2018 on the joint use of customer support systems, and in February 2019 on the joint development of a new distribution model for generic and specialty pharmaceuticals.」

「The company also worked to promote the adoption of proprietary customer support systems such as the Initial Consultation Reception Service, ENIFvoice SP+A / ENIFvoice Core and Core POS.」

「The company also worked to promote the adoption of proprietary customer support systems such as the Initial Consultation Reception Service and ENIFvoice SP+A / ENIFvoice Core.」

「The company also worked to promote the adoption of proprietary customer support systems, including the Initial Consultation Reception Service and ENIFvoice Core.」

「The company positioned its proprietary customer support systems as a major source of revenue, actively sought to increase contracts for the Initial Consultation Reception Service and ENIFvoice SP+A / ENIFvoice Core, and worked to strengthen relationships with medical institutions through proposal activities.」

「The company positioned its proprietary customer support systems as a major source of revenue, actively sought to increase the number of contracts, and worked to strengthen relationships with medical institutions through its proposal activities.」

「As a major source of revenue, the company actively developed and proposed customer support systems that help resolve issues faced by patients and medical institutions and improve their profitability, with a particular focus on securing contracts for the Initial Consultation Reception Service and ENIFvoice SP/SP+A.」

「The company also worked to accelerate the adoption of customer support systems, particularly by expanding contracts for Hospital Navi, the Initial Consultation Reception Service and ENIFvoice SP.」

「The company sought to expand its fee-based business by focusing on proposals for its proprietary customer support systems.」

「Against this backdrop, the company worked to increase contracts for its proprietary customer support systems while continuing to promote expense controls.」

「The increase in contracts for the company's proprietary customer support systems, together with the cost-control effect on selling, general and administrative expenses, also contributed.」

「The company continues to develop and propose various customer support systems and services that address issues faced by patients and medical institutions.」

「The company worked on developing and proposing various customer support systems to address the issues faced by patients and medical institutions.」